• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心房颤动与心力衰竭关系的流行病学]

[Epidemiology of the relationship between atrial fibrillation and heart failure].

作者信息

Ragbaoui Yassine, Chehbouni Chafia, Hammiri Ayoub El, Habbal Rachida

机构信息

Service de Cardiologie, Centre Hospitalier Universitaire IBN ROCHD, Casablanca, Maroc.

出版信息

Pan Afr Med J. 2017 Mar 2;26:116. doi: 10.11604/pamj.2017.26.116.11470. eCollection 2017.

DOI:10.11604/pamj.2017.26.116.11470
PMID:28533839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5429405/
Abstract

Atrial fibrillation and heart failure are diseases which often coexist aggravating prognosis and constituting a major public health problem. The aim of this study was to assess the prevalence of atrial fibrillation in patients with chronic heart failure and to determine the clinical profile of this group of patients. We conducted a retrospective descriptive study based on the registry of heart failure of the Department of Cardiology at the University Hospital Centre from June 2006 to March 2015. All patients over 18 years of age with chronic heart failure associated with atrial fibrillation were included in the study. During the study period 3048 patients with chronic heart failure associated with atrial fibrillation (AF) were enrolled. The prevalence of heart failure was 10.6%. The frequency of cardiovascular risk factors associated with (AF) was: (54%) hypertension, (39%) diabetes, (8%) dyslipidemia, (26%) tobacco, (30%) sedentary lifestyle and (17%) menopause. FA affected 67.4% of men and 32.6% of women. The causes of chronic heart failure associated with atrial fibrillation were: heart valve diseases (44;1%); coronary artery diseases (32%); hypertensive (11%), primary (10%), toxic (2%) and chronic alcoholism (1%). Atrial fibrillation frequently appears in patients with heart failure in Morocco and it occurs at an average age lower than that found in the literature.

摘要

心房颤动与心力衰竭常并存,会加重病情预后,构成一个重大的公共卫生问题。本研究旨在评估慢性心力衰竭患者中心房颤动的患病率,并确定该组患者的临床特征。我们基于大学医院中心心脏病科2006年6月至2015年3月的心力衰竭登记资料进行了一项回顾性描述性研究。所有18岁以上合并心房颤动的慢性心力衰竭患者均纳入本研究。研究期间,共纳入3048例合并心房颤动(AF)的慢性心力衰竭患者。心力衰竭的患病率为10.6%。与(AF)相关的心血管危险因素的发生率为:高血压(54%)、糖尿病(39%)、血脂异常(8%)、吸烟(26%)、久坐不动的生活方式(30%)和绝经(17%)。心房颤动在男性中的发生率为67.4%,在女性中的发生率为32.6%。合并心房颤动的慢性心力衰竭的病因有:心脏瓣膜病(44;1%)、冠状动脉疾病(32%)、高血压(11%)、原发性(10%)、中毒性(2%)和慢性酒精中毒(1%)。在摩洛哥,心房颤动在心力衰竭患者中经常出现,且其发病的平均年龄低于文献报道。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d091/5429405/814587b0e637/PAMJ-26-116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d091/5429405/8441572e979f/PAMJ-26-116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d091/5429405/814587b0e637/PAMJ-26-116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d091/5429405/8441572e979f/PAMJ-26-116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d091/5429405/814587b0e637/PAMJ-26-116-g002.jpg

相似文献

1
[Epidemiology of the relationship between atrial fibrillation and heart failure].[心房颤动与心力衰竭关系的流行病学]
Pan Afr Med J. 2017 Mar 2;26:116. doi: 10.11604/pamj.2017.26.116.11470. eCollection 2017.
2
Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.慢性阻塞性肺疾病对心房颤动预后的影响:欧洲观察性研究计划心房颤动试点调查(EORP-AF)总登记处的报告
Am Heart J. 2016 Nov;181:83-91. doi: 10.1016/j.ahj.2016.08.011. Epub 2016 Aug 27.
3
A review of the epidemiological profile of patients with atrial fibrillation and heart failure.心房颤动合并心力衰竭患者的流行病学概况综述。
Expert Rev Cardiovasc Ther. 2012 Sep;10(9):1133-40. doi: 10.1586/erc.12.110.
4
[Epidemiology and nosology of atrial fibrillation].[心房颤动的流行病学与疾病分类学]
Arch Mal Coeur Vaiss. 1994 Sep;87 Spec No 3:11-5.
5
Hyperuricemia as a risk factor for cardiovascular disease: clinical review.高尿酸血症作为心血管疾病的危险因素:临床综述
Medwave. 2016 Nov 15;16(10):e6606. doi: 10.5867/medwave.2016.10.6606.
6
Prevalence and risk factors of atrial fibrillation in preterminal inpatients aged 60 years and over.60岁及以上临终住院患者心房颤动的患病率及危险因素
Chin Med J (Engl). 2008 Oct 20;121(20):2046-9.
7
Atrial fibrillation in heart failure in the older population.老年人心力衰竭中的心房颤动。
Heart Fail Clin. 2013 Oct;9(4):451-9, viii-ix. doi: 10.1016/j.hfc.2013.07.007.
8
Therapeutical considerations in associated atrial fibrillation and heart failure.合并心房颤动与心力衰竭的治疗考量
Rev Med Chir Soc Med Nat Iasi. 2014 Jul-Sep;118(3):624-30.
9
Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial.根据心房颤动类型,抗凝治疗患者发生中风和死亡的残余风险:AMADEUS试验
Stroke. 2015 Sep;46(9):2523-8. doi: 10.1161/STROKEAHA.115.009487. Epub 2015 Jul 23.
10
Prevalence and predisposing conditions for atrial fibrillation in hospitalised patients with hypertension.高血压住院患者心房颤动的患病率及易患因素。
Kardiol Pol. 2013;71(4):352-8. doi: 10.5603/KP.2013.0062.

引用本文的文献

1
Management and Anticoagulation Treatment of Non-Valvular Atrial Fibrillation in Elderly Patients: The Dali Study.老年非瓣膜性心房颤动的管理与抗凝治疗:大理研究
Int J Gen Med. 2023 Aug 14;16:3491-3501. doi: 10.2147/IJGM.S418674. eCollection 2023.
2
Brain Imaging Changes and Related Risk Factors of Cognitive Impairment in Patients With Heart Failure.心力衰竭患者认知障碍的脑成像变化及相关危险因素
Front Cardiovasc Med. 2022 Jan 26;8:838680. doi: 10.3389/fcvm.2021.838680. eCollection 2021.
3
[Observational study of the prevalence of non-valvular atrial fibrillation and ischemic stroke and the factors associated with non-valvular atrial fibrillation in hypertensive patients: about 2887 cases].

本文引用的文献

1
[Epidemiology and management of heart failure in a Moroccan center].[摩洛哥某中心心力衰竭的流行病学与管理]
Pan Afr Med J. 2016 May 27;24:85. doi: 10.11604/pamj.2016.24.85.8521. eCollection 2016.
2
The Paradox of Heart Failure and Atrial Fibrillation.
J Am Coll Cardiol. 2016 Sep 13;68(11):1252-1253. doi: 10.1016/j.jacc.2016.05.094.
3
[Epidemiology and etiology of heart failure in Lome].[洛美心力衰竭的流行病学与病因学]
Pan Afr Med J. 2014 Jun 25;18:183. doi: 10.11604/pamj.2014.18.183.3983. eCollection 2014.
高血压患者非瓣膜性心房颤动和缺血性卒中患病率及与非瓣膜性心房颤动相关因素的观察性研究:约2887例
Pan Afr Med J. 2021 Jan 13;38:31. doi: 10.11604/pamj.2021.38.31.25569. eCollection 2021.
4
Do age-associated changes of voltage-gated sodium channel isoforms expressed in the mammalian heart predispose the elderly to atrial fibrillation?哺乳动物心脏中表达的电压门控钠通道亚型的年龄相关变化会使老年人易患心房颤动吗?
World J Cardiol. 2020 Apr 26;12(4):123-135. doi: 10.4330/wjc.v12.i4.123.
4
Heart disease and stroke statistics--2014 update: a report from the American Heart Association.《2014年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2014 Jan 21;129(3):e28-e292. doi: 10.1161/01.cir.0000441139.02102.80. Epub 2013 Dec 18.
5
Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population.美国成年人群中心房颤动当前和未来的发病率和患病率估计。
Am J Cardiol. 2013 Oct 15;112(8):1142-7. doi: 10.1016/j.amjcard.2013.05.063. Epub 2013 Jul 4.
6
Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry.在常规临床实践中阵发性、持续性和永久性心房颤动的分布和风险特征:来自真实世界全球调查评估心房颤动国际登记研究的见解。
Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):632-9. doi: 10.1161/CIRCEP.112.970749. Epub 2012 Jul 11.
7
Atrial fibrillation in heart failure: a comprehensive review.心力衰竭中的心房颤动:全面综述。
Am J Med. 2010 Mar;123(3):198-204. doi: 10.1016/j.amjmed.2009.06.033.
8
Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon.非洲的心房颤动:喀麦隆的临床特征、预后和指南遵循情况。
Europace. 2010 Apr;12(4):482-7. doi: 10.1093/europace/euq006. Epub 2010 Feb 23.
9
Pattern of heart failure in Abuja, Nigeria: an echocardiographic study.尼日利亚阿布贾心力衰竭模式:一项超声心动图研究。
Cardiovasc J Afr. 2009 Nov-Dec;20(6):349-52.
10
Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry.β受体阻滞剂在心力衰竭中的临床疗效:来自优化心力衰竭治疗(OPTIMIZE-HF,住院心力衰竭患者启动挽救生命治疗的组织项目)注册研究的结果
J Am Coll Cardiol. 2009 Jan 13;53(2):184-92. doi: 10.1016/j.jacc.2008.09.031.